{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:44:26Z","timestamp":1782891866137,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["2405-043-1535"],"award-info":[{"award-number":["2405-043-1535"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000032","name":"Institute of Infection and Immunity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016341","name":"Korea University Guro Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jgar.2025.08.012","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:19:01Z","timestamp":1756307941000},"page":"70-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimising personalised antibiotic treatment for methicillin-resistant Staphylococcus aureus bloodstream infections in ICU patients using a deep learning\u2013based causal inference approach"],"prefix":"10.1016","volume":"45","author":[{"given":"Min Woo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-0614","authenticated-orcid":false,"given":"Shin Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jgar.2025.08.012_bib0001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ajic.2003.09.002","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003","volume":"31","year":"2003","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.jgar.2025.08.012_bib0002","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/0256-4947.67077","article-title":"Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007","volume":"30","author":"Al-Talib","year":"2010","journal-title":"Ann Saudi Med"},{"issue":"12","key":"10.1016\/j.jgar.2025.08.012_bib0003","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.jgar.2025.08.012_bib0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jgar.2025.08.012_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/502527","article-title":"Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?","volume":"26","author":"Lesens","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.jgar.2025.08.012_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3346\/jkms.2010.25.7.992","article-title":"Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals","volume":"25","author":"Son","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0007","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nature Rev Dis Primers"},{"key":"10.1016\/j.jgar.2025.08.012_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/1179916117703999","article-title":"An update on clinical burden, diagnostic tools, and therapeutic options of Staphylococcus aureus","volume":"10","author":"Reddy","year":"2017","journal-title":"Infect Dis (Auckl)"},{"issue":"4","key":"10.1016\/j.jgar.2025.08.012_bib0009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nature Rev Microbiol"},{"issue":"19","key":"10.1016\/j.jgar.2025.08.012_bib0010","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","article-title":"Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"162","author":"Blot","year":"2002","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jgar.2025.08.012_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijantimicag.2011.05.013","article-title":"Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study","volume":"38","author":"Hanberger","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0012","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12879-021-05763-y","article-title":"Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.jgar.2025.08.012_bib0013","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.CCM.0000178180.61305.1D","article-title":"Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides*","volume":"33","author":"Rello","year":"2005","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jgar.2025.08.012_bib0014","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jgar.2025.08.012_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of Vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jgar.2025.08.012_bib0016","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1128\/AAC.00824-07","article-title":"Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells","volume":"51","author":"Mascio","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.08.012_bib0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CE.S33430","article-title":"An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy","volume":"7","author":"Watkins","year":"2012","journal-title":"Core Evid"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13054-017-1653-x","article-title":"A path to precision in the ICU","volume":"21","author":"Maslove","year":"2017","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"npj Digital Med"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.35","article-title":"MIMIC-III, a freely accessible critical care database","volume":"3","author":"Johnson","year":"2016","journal-title":"Sci Data"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"10.1016\/j.jgar.2025.08.012_bib0022","series-title":"Proceedings of the 33rd International Conference on Neural Information Processing Systems","article-title":"Adapting neural networks for the estimation of treatment effects","author":"Shi","year":"2019"},{"key":"10.1016\/j.jgar.2025.08.012_bib0023","series-title":"International Conference on Machine Learning","article-title":"Estimating individual treatment effect: generalization bounds and algorithms","author":"Shalit","year":"2016"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0024","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41746-023-00961-1","article-title":"Causal inference using observational intensive care unit data: a scoping review and recommendations for future practice","volume":"6","author":"Smit","year":"2023","journal-title":"NPJ Digit Med"},{"issue":"5","key":"10.1016\/j.jgar.2025.08.012_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cmi.2019.09.009","article-title":"Machine learning for clinical decision support in infectious diseases: a narrative review of current applications","volume":"26","author":"Peiffer-Smadja","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jgar.2025.08.012_bib0026","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jgar.2025.08.012_bib0027","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/AAC.00227-16","article-title":"Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"60","author":"Claeys","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jgar.2025.08.012_bib0028","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkm271","article-title":"Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections","volume":"60","author":"Stein","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"9 Suppl","key":"10.1016\/j.jgar.2025.08.012_bib0029","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1097\/01.inf.0000086954.43010.63","article-title":"Linezolid pharmacokinetics in pediatric patients: an overview","volume":"22","author":"Jungbluth","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jgar.2025.08.012_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/annonc\/mdg211","article-title":"Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia","volume":"14","author":"Smith","year":"2003","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.jgar.2025.08.012_bib0031","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00277-018-3367-9","article-title":"Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation","volume":"97","author":"Qu","year":"2018","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.jgar.2025.08.012_bib0032","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jiac.2019.08.018","article-title":"Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: a multicenter prospective observational cohort study","volume":"26","author":"Miyazaki","year":"2020","journal-title":"J Infect Chemother"},{"issue":"10","key":"10.1016\/j.jgar.2025.08.012_bib0033","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s12630-022-02282-5","article-title":"White blood cell count trajectory and mortality in septic shock: a historical cohort study","volume":"69","author":"Rimmer","year":"2022","journal-title":"Can J Anaesth"},{"issue":"5","key":"10.1016\/j.jgar.2025.08.012_bib0034","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jmii.2023.07.010","article-title":"Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: the importance of treatment response rather than bacteremia duration","volume":"56","author":"Kim","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"10.1016\/j.jgar.2025.08.012_bib0035","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jgar.2025.08.012_bib0036","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00228-012-1340-4","article-title":"Decreased vancomycin clearance in patients with congestive heart failure","volume":"69","author":"Shimamoto","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jgar.2025.08.012_bib0037","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12879-019-4077-1","article-title":"Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis","volume":"19","author":"Gaudard","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.jgar.2025.08.012_bib0038","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/phar.2475","article-title":"Optimization of vancomycin dosing regimen in cancer patients using pharmacokinetic\/pharmacodynamic modeling","volume":"40","author":"Alqahtani","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.jgar.2025.08.012_bib0039","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1078155209355847","article-title":"Pharmacokinetics of vancomycin in adult cancer patients","volume":"16","author":"Al-Kofide","year":"2010","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"10.1016\/j.jgar.2025.08.012_bib0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s13181-010-0047-0","article-title":"Severe drug-induced liver injury associated with prolonged use of linezolid","volume":"6","author":"De Bus","year":"2010","journal-title":"J Med Toxicol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T22:02:48Z","timestamp":1780783368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S2213716525001936"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.08.012","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising personalised antibiotic treatment for methicillin-resistant Staphylococcus aureus bloodstream infections in ICU patients using a deep learning\u2013based causal inference approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}